NCT06994676
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06994676
Title A Study of CBX-250 in Participants With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (CROSSCHECK-001)
Acronym CROSSCHECK-001
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Crossbow Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
Washington University in St. Louis RECRUITING St Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Sarah Cannon Cancer Institute RECRUITING Nashville Tennessee 37203 United States Details
Vanderbilt University Medical Center RECRUITING Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field